Skip to main content
Smita Dharwad
Smita Dharwad © Smita Shivanand Dharwad

Dr. Smita Dharwad

NIMS University
Professor of Oral and Maxillofacial Pathology and Oral Microbiology
India
Program

Sessions with Smita Dharwad

About Smita Dharwad

Dr. Smita Shivanand Dharwad is a distinguished dental professional and academician currently serving as an Associate Professor of Oral and Maxillofacial Pathology and Oral Microbiology at NIMS University Rajasthan, India. An alumna of Rajiv Gandhi University of Health Sciences, she achieved the prestigious 7th university rank during her MDS specializing in Oral Pathology and Microbiology. Her professional expertise is anchored in high-demand diagnostic and research modalities, including molecular techniques like PCR, ELISA and Immunohistochemistry, as well as advancing fields such as Cell culture, Nanobiotechnology and Digital pathology. A dedicated researcher, Dr. Smita has made significant contributions to the literature, most notably through a multi-centre study in India addressing the variability in grading systems for oral epithelial dysplasia. Her significant research portfolio includes studies on Multiplex PCR detection of microbial species in endodontic infections, PCR-based detection of high-risk HPV genotypes and the exploration of immune markers in Oral squamous cell carcinoma and other oral lesions. Beyond the classroom and lab, she actively engages with the National scientific community with her participation in various conferences, conventions and slide seminars covering diverse topics from odontogenic tumours to salivary gland pathology and sharing her insights through scientific presentations and chairing sessions. On the international stage, Dr. Smita recently served as a speaker at the WHS Academic Alliance Expert Meeting in Rome in June 2026, where she presented on the emerging field of Salivary Biomarkers and Cancer. Beyond her academic and research commitments, she remains a dedicated advocate for public health initiatives through early chair-side screening for oral pre-cancerous lesions and community-based tobacco awareness programs.